Fibromuscular dysplasia of the renal arteries: What do we know in 2024? (notice n° 192115)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01548cam a2200193 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250112044757.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Tournebize, Corentin |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Fibromuscular dysplasia of the renal arteries: What do we know in 2024? |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2024.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 61 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Fibromuscular dysplasia (FMD) is a rare nonatherosclerotic, noninflammatory vascular disease that most often affects the renal and carotid arteries and is the second most frequent cause of renal artery stenosis. The symptomatology is dominated by arterial hypertension due to the frequent involvement of the renal arteries and depends on the location of the lesions. Most of the cases are middle-aged women of Caucasian origin. There are two subtypes based on angiographic aspect: multifocal FMD (80% of the cases), and focal FMD (rarer with a more balanced sex ratio). Angioplasty of the renal arteries is generally disappointing, with a less-than-50% success rate when it comes to curing hypertension. It appears necessary to improve our knowledge of FMD and to optimize the selection of eligible patients for revascularization by way of transdisciplinary collegial therapeutic decisions. |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lemoine, Sandrine |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pelletier, Caroline |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pelletier, Caroline |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Néphrologie & Thérapeutique | Volume 20 | 2 | 2024-02-01 | p. 131-139 | 1769-7255 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-nephrologie-therapeutique-2024-2-page-131?lang=en">https://shs.cairn.info/journal-nephrologie-therapeutique-2024-2-page-131?lang=en</a> |
Pas d'exemplaire disponible.
Réseaux sociaux